HK1109069A1 - Vaccine composition against hepatitis c virus - Google Patents

Vaccine composition against hepatitis c virus

Info

Publication number: HK1109069A1
Authority: HK; Hong Kong
Prior art keywords: virus; vaccine composition; composition against; against hepatitis; hepatitis
Prior art date: 2004-09-03

Application number

HK07114321A

Other languages

English (en)

Inventor

A Musacchio Lasa

S Duenas Carrera

L Alvarez-Lajonchere Ponce De Leon

N Acosta Rivero

G Martinez Donato

M Guirola Tsibulova

G Sardinas Garcia

Original Assignee

Ct Ingenieria Genetica Biotech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-03

Filing date

2007-12-31

Publication date

2008-05-30

2007-12-31 Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech

2008-05-30 Publication of HK1109069A1 publication Critical patent/HK1109069A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

HK07114321A 2004-09-03 2007-12-31 Vaccine composition against hepatitis c virus HK1109069A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CU20040189A CU23496A1 (es)	2004-09-03	2004-09-03	Composición vacunal contra el virus de la hepatitis c
PCT/CU2005/000005 WO2006024240A2 (es)	2004-09-03	2005-08-29	Composición vacunal contra el virus de la hepatitis c.

Publications (1)

Publication Number	Publication Date
HK1109069A1 true HK1109069A1 (en)	2008-05-30

Family

ID=40262832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK07114321A HK1109069A1 (en)	2004-09-03	2007-12-31	Vaccine composition against hepatitis c virus

Country Status (15)

Country	Link
US (1)	US20080138360A1 (xx)
EP (1)	EP1785143B1 (xx)
JP (1)	JP4917539B2 (xx)
KR (1)	KR101245154B1 (xx)
CN (1)	CN101043902B (xx)
AR (1)	AR052639A1 (xx)
AU (1)	AU2005279590B2 (xx)
BR (1)	BRPI0514884A (xx)
CA (1)	CA2577918C (xx)
CU (1)	CU23496A1 (xx)
HK (1)	HK1109069A1 (xx)
MX (1)	MX2007002659A (xx)
RU (1)	RU2351363C2 (xx)
WO (1)	WO2006024240A2 (xx)
ZA (1)	ZA200701674B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG10201502490YA (en)	2006-09-29	2015-05-28	Ligocyte Pharmaceuticals Inc	Norovirus vaccine formulations
KR20100083150A (ko)	2007-09-18	2010-07-21	리고사이트 파머슈티컬즈 인코퍼레이티드	노로바이러스에 대한 보호면역반응을 제공하는 방법
US20100266636A1 (en)	2007-09-18	2010-10-21	Ligocyte Pharmaceuticals, Inc.	Method of conferring a protective immune response to norovirus
PL2324113T3 (pl) *	2008-08-08	2018-08-31	Takeda Vaccines, Inc.	Cząstki wirusopodobne zawierające złożone kapsydowe sekwencje aminokwasowe do zwiększonej reaktywności krzyżowej
MY170746A (en)	2011-07-11	2019-08-27	Takeda Vaccines Inc	Parenteral norovirus vaccine formulations
RU2510998C2 (ru) *	2012-08-01	2014-04-10	Николай Николаевич Грановский	ВАКЦИНА НА ОСНОВЕ ВИРУСОПОДОБНЫХ ЧАСТИЦ, СОДЕРЖАЩИХ ВСЕ СТРУКТУРНЫЕ АНТИГЕНЫ ВИРУСА ГЕПАТИТА С, И СПОСОБ ЕЕ ПОЛУЧЕНИЯ В ДРОЖЖАХ Hansenula polymorpha
CU24112B1 (es) *	2012-11-05	2015-08-27	Ct De Ingeniería Genética Y Biotecnología	Antígenos vacunales quiméricos contra el virus de la hepatitis c

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7070790B1 (en) *	1993-06-29	2006-07-04	The United States Of America As Represented By The Department Of Health And Human Services	Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
CA2202088A1 (en) *	1994-10-05	1996-04-18	Catherine J. Pachuk	Hepatitis virus vaccines
CA2269097C (en) *	1996-11-08	2007-01-09	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Synthesis and purification of hepatitis c virus-like particles
CA2391843C (en) *	1999-11-19	2011-10-18	Csl Limited	Hcv vaccine compositions
AU2002225895A1 (en) *	2000-11-07	2002-05-21	Anadys Pharmaceuticals, Inc.	Hepatitis c virus constructs characterized by high efficiency replication
US7101561B2 (en) *	2000-12-01	2006-09-05	Innogenetics N.V.	Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US20030021805A1 (en) *	2001-05-29	2003-01-30	Barber Glen N.	Generation of HCV-like particles and chimeric HCV virus
CU23244A1 (es) *	2001-07-16	2007-10-17	Ct Ingenieria Genetica Biotech	Formulacion vacunal potenciada por la combinacion de un adn con un antigeno
DE10143490C2 (de) *	2001-09-05	2003-12-11	Gsf Forschungszentrum Umwelt	Rekombinantes MVA mit der Fähigkeit zur Expression von HCV Struktur-Antigenen

2004
- 2004-09-03 CU CU20040189A patent/CU23496A1/es not_active IP Right Cessation
2005
- 2005-08-22 AR ARP050103513 patent/AR052639A1/es not_active Application Discontinuation
- 2005-08-29 CA CA 2577918 patent/CA2577918C/en not_active Expired - Fee Related
- 2005-08-29 JP JP2007528569A patent/JP4917539B2/ja not_active Expired - Fee Related
- 2005-08-29 US US11/661,217 patent/US20080138360A1/en not_active Abandoned
- 2005-08-29 RU RU2007112117A patent/RU2351363C2/ru not_active IP Right Cessation
- 2005-08-29 WO PCT/CU2005/000005 patent/WO2006024240A2/es active Application Filing
- 2005-08-29 MX MX2007002659A patent/MX2007002659A/es active IP Right Grant
- 2005-08-29 CN CN2005800362181A patent/CN101043902B/zh not_active Expired - Fee Related
- 2005-08-29 BR BRPI0514884-7A patent/BRPI0514884A/pt not_active IP Right Cessation
- 2005-08-29 KR KR1020077006792A patent/KR101245154B1/ko not_active IP Right Cessation
- 2005-08-29 AU AU2005279590A patent/AU2005279590B2/en not_active Ceased
- 2005-08-29 EP EP20050779477 patent/EP1785143B1/en active Active
2007
- 2007-02-26 ZA ZA200701674A patent/ZA200701674B/xx unknown
- 2007-12-31 HK HK07114321A patent/HK1109069A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
AR052639A1 (es)	2007-03-28
AU2005279590A1 (en)	2006-03-09
JP2008511556A (ja)	2008-04-17
US20080138360A1 (en)	2008-06-12
MX2007002659A (es)	2007-05-16
KR20070057861A (ko)	2007-06-07
AU2005279590B2 (en)	2010-12-16
CN101043902B (zh)	2012-04-18
ZA200701674B (en)	2008-08-27
CA2577918C (en)	2013-05-28
JP4917539B2 (ja)	2012-04-18
EP1785143A2 (en)	2007-05-16
BRPI0514884A (pt)	2008-06-24
CA2577918A1 (en)	2006-03-09
CN101043902A (zh)	2007-09-26
RU2007112117A (ru)	2008-10-10
EP1785143B1 (en)	2015-03-04
KR101245154B1 (ko)	2013-03-19
WO2006024240A2 (es)	2006-03-09
RU2351363C2 (ru)	2009-04-10
WO2006024240A3 (es)	2006-06-01
CU23496A1 (es)	2010-02-23

Publication	Publication Date	Title
IL200432A0 (en)	2010-04-29	Human antibodies against hepatitis c virus (hcv) uses thereof
AP2406A (en)	2012-05-02	Macrocydic inhibitors of hepatitis C virus.
HK1123055A1 (en)	2009-06-05	Hepatitis c virus nucleic acid vaccine
EP1684787A4 (en)	2009-08-05	INHIBITORS OF HEPATITIS C VIRUS
EP1684745A4 (en)	2008-11-19	INHIBITORS OF HEPATITIS C VIRUS
HRP20160410T8 (hr)	2019-04-19	Inhibitori hepatitis c virusa
EP1603590A4 (en)	2008-08-27	INFLUENZA VIRUS VACCINE
AP2907A (en)	2014-05-31	Viral hepatitis treatment
IL198248A0 (en)	2009-12-24	Hepatitis c virus inhibitors and compositions comprising the same
IL189329A0 (en)	2008-06-05	Vaccination against dengue virus infection
HK1223968A1 (zh)	2017-08-11	狂犬病病毒組合物和方法
ZA200709518B (en)	2014-01-29	Vaccine composition
EP1765385A4 (en)	2008-08-27	IMPORTS COMPOSITION WITH DELAYED RELEASE
HK1109069A1 (en)	2008-05-30	Vaccine composition against hepatitis c virus
GB0416487D0 (en)	2004-08-25	Modified virus
GB0328753D0 (en)	2004-01-14	Hepatitis B vaccines
ZA200802176B (en)	2009-08-26	Vaccination against dengue virus infection
AU2004904920A0 (en)	2004-09-16	Hepatitis C Virus Epitopes
GB0421916D0 (en)	2004-11-03	Hepatitis C virus replication system
GB0403743D0 (en)	2004-03-24	Vaccine composition
GB0501582D0 (en)	2005-03-02	Hepatitis c virus replication system
AU2004903497A0 (en)	2004-07-08	Hepatitis B virus polymerase
HUS1500008I1 (hu)	2016-10-28	Hepatitis C vírus inhibitorok
GB0502569D0 (en)	2005-03-16	Vaccine composition
ZA200903014B (en)	2010-07-28	Hepatitis C virus inhibitors

Legal Events

Date	Code	Title	Description
2018-03-29	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20170829